|
Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish logistics hub Biostor Ireland Ltd, following approval from the Irish Health Products Regulatory Authority in October. The logistics hub provides a central European location for the distribution of its allograft products throughout the EU, ‘facilitating increased shipments across the EU and aiding the potential for further partnerships and distributor contracts within these countries’. Tissue Regenix also signs two new distributor agreements for its allograft products in Turkey and Ireland, including Northern Ireland. Says these agreements cover the dental and orthopaedic markets and continue the expansion of its EU coverage. This follows the recently announced exclusive distributor agreement in Spain with Spineart Espana SLU. Tissue Regenix says these developments are in line with its commercial strategy of expanding its distribution network and growing market share in other jurisdictions outside the US. Current stock price: 62.70 pence 12-month change: down 2.8% Copyright 2024 Alliance News Ltd. All Rights Reserved.
|
